Lilly Acquires AurKa Pharma
Eli Lilly and Company
has acquired
AurKa Pharma, Inc.
$110,000,000 plus
up to $465,000,000
in regulatory and sales
milestones
Eli Lilly and Company
has acquired
AurKa Pharma, Inc.
$110,000,000 plus
up to $465,000,000
in regulatory and sales
milestones